Dr Ian E Haines MBBS FRACP FAChPM

Ian Haines is a practising medical oncologist in the Melbourne Oncology Group, Cabrini Hospital, and Adjunct Clinical Associate Professor in the AMREP Department of Medicine, Monash University, Melbourne, Australia. He is also Honorary Visiting Medical Officer to the Medical Oncology Unit at the Alfred hospital, Melbourne, Australia. He worked previously as a clinical and research fellow in medical oncology at the Memorial Sloan-Kettering Cancer Center in New York, NY.

In Melbourne, he provides inpatient and outpatient cancer care and participates comprehensively in research and teaching. In association with his network of professional colleagues, he aims to provide the highest standards of treatment that cure the patient’s cancer or alternatively prolong the patient’s overall survival and enhance the quality of their life. He seeks to provide compassionate, comprehensive and competent care by providing his patients and their loved ones with realistic goals, open lines of communication and cost-effective options, He also manages the outpatient care of many non-insured, as well as privately insured patients.

In 1987, he established the medical oncology service at Cabrini Hospital and founded the multidisciplinary Melbourne Oncology Group, one of the first private practice specialist oncology referral groups in Australia, which brought together expertise in medical oncology, haematology, genetic counselling, palliative care and psycho-oncology in the same office. He helped build the Medical Oncology Treatment Unit at Cabrini hospital to provide separate and dedicated inpatient, day patient and acute palliative care units. He also helped establish the hospital’s own dedicated 24-hour domiciliary care service.  He further instantiated an after-hours roster to provide continuous 24 hour cover specialist medical cover for all Cabrini cancer patients, employing many young medical oncology specialists. The Cabrini multidisciplinary Oncology Service has grown to now be one of the largest in Australasia, private or public.

He is a member of various Commonwealth and/or Victorian government public entities including advisory committees of the Cancer Council Victoria, and membership of the Ethics sub-committee of the Medical Oncology Group of Australia. He has extensive experience in evaluating the data from clinical trials and has been the principal investigator and co-investigator on various industry and co-operative group sponsored clinical cancer trials. He has published on breast cancer, prostate cancer, lymphoma and chronic lymphocytic leukemia and is a leading advocate for open-access data and for the disclosure of conflicts of interest in medical research.

Publications

Differences in treatment choices for localised prostate cancer diagnosed in private and public health services

Med J Aust. 2020 Nov;213(9):411-417. doi: 10.5694/mja2.50794. Epub 2020 Sep 30.PMID: 32996611

Te Marvelde L, Milne RL, Hornby CJ, Chapman AB, Giles GG, Haines IE.

Bevacizumab Moonshots: An Important Outcome From the Latest Ovarian Cancer Mission

J Clin Oncol. 2020 Jan 10;38(2):171-172. doi: 10.1200/JCO.19.01912. Epub 2019 Nov 7.PMID: 31697588

Haines IE, Gabor Miklos GL.

PARP Inhibitors in Ovarian Cancer

N Engl J Med. 2020 Apr 16;382(16):1573. doi: 10.1056/NEJMc2000644.PMID: 32294362 Haines IE, Gabor Miklos GL.

Latest data on prostate cancer treatment: jaw dropping and clearcut

Medical Journal of Australia InSight. 2017. Issue 29, 31 July.

Haines IE and Gabor Miklos GL.

Authors' reply to Kole

BMJ. 2016 Jul 12;354:i3795. doi: 10.1136/bmj.i3795.PMID: 27406205

Haines IE, Ablin RJ, Miklos GL.

Is there a baby in the bathwater to throw out? Unresolved issues in the dominant prostate-specific antigen screening trial 

Journal of Clinical Oncology, DOI: 0.1200/jco.2016.69.8795, Ian E Haines

The scandal of prostate cancer management in Australia

2016, Medical Journal of Australia, Insight, November 21st  issue 45. Ian E Haines  

Screening for prostate cancer: time to put all the data on the table

2016, British Medical Journal, 353, I2574 DOI: 10.1136/Bmj.I2574, Ian E Haines, Richard J Ablin And George L Gabor Miklos 

Prostate cancer screening in Europe

2015, The Lancet, 385, 1506, DOI: 1016/S0140-6736(15)60747-4, Ian E Haines, Richard J Ablin And George L Gabor Miklos

Folfoxiri and bevacizumab for metastatic colorectal cancer

2014, New England Journal Of Medicine, 372, 290-291, Ian E Haines

Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection (response to carlsson)

2014, Journal Of The National Cancer Institute, Advance Access, April, Doi:10.1093/Jnci/Dju081, Ian E Haines And George L Gabor Miklos

Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection (response to walsh, 2014)

2014, Journal of The National Cancer Institute. feb, 106(2):djt433, Ian E Haines And George L Gabor Miklos

Strategies to help oncologists deliver high-quality care

2014, Journal of Clinical Oncology, 32, 1977-1978, Ian E Haines

PSA screening, lives saved, and hormonal monotherapy: it’s time to face some quietly ignored facts

2014,  Uro Today, Ian E Haines And George L Gabor Miklos

Bevacizumab for newly diagnosed glioblastoma. 

2014, New England Journal of Medicine, May 22, 370, 2048, Ian E Haines And George L Gabor Miklos

Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection

2013, Journal Of The National Cancer Institute, Ian E Haines And George L Gabor Miklos

Time to mandate data release and independent audits for all clinical trials

2011, Medical Journal of Australia, 195, 575-577. Ian E Haines And George L Gabor Miklos

Quality-of-life-effects of prostate-specific antigen screening

2012, New England Journal of Medicine, 367, 1861, Ian E Haines

Managing patients with advanced cancer: the benefits of early referral for palliative care

2011, Medical Journal of Australia, 194, 107-8, Ian E Haines

What changes are needed to the current direction of and interpretation of clinical cancer research to meet the needs of the 21st century

2009, Medical Journal Of Australia, 190, 74-77, I N Olver And Ian E Haines

Paclitaxel plus bevacizumab for metastatic breast cancer

2008, New England Journal of Medicine, 358, 1637, Ian E Haines And George L Gabor Miklos

Ian Haines has appeared on the four corners program, buying time, produced by the Australian broadcasting commission, and also has a specific segment, “a personal video interview with Dr Ian Haines” as a fuller interview.

http://www.abc.net.au/4corners/stories/2013/08/26/3831617.htm